/* This file is part of OpenMalaria.
 * 
 * Copyright (C) 2005-2021 Swiss Tropical and Public Health Institute
 * Copyright (C) 2005-2015 Liverpool School Of Tropical Medicine
 * Copyright (C) 2020-2022 University of Basel
 *
 * OpenMalaria is free software; you can redistribute it and/or modify
 * it under the terms of the GNU General Public License as published by
 * the Free Software Foundation; either version 2 of the License, or (at
 * your option) any later version.
 * 
 * This program is distributed in the hope that it will be useful, but
 * WITHOUT ANY WARRANTY; without even the implied warranty of
 * MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE.  See the GNU
 * General Public License for more details.
 * 
 * You should have received a copy of the GNU General Public License
 * along with this program; if not, write to the Free Software
 * Foundation, Inc., 51 Franklin Street, Fifth Floor, Boston, MA 02110-1301, USA.
 */

#ifndef Hmod_util_ModelOptions
#define Hmod_util_ModelOptions

#include "Global.h"
#include <bitset>

class UnittestUtil;

namespace scnXml{ class OptionSet; }
namespace OM { namespace util {
    
    /** Flags signalling which versions of some models to use. */
    enum OptionCodes {
	/* @brief Clinical episodes reduce the level of acquired immunity
	* 
	* Effective cumulative exposure to blood stage parasites is reduced by a
	* clinical sickness event, so that clinical bouts have a negative effect on
	* blood stage immunity.
	* 
	* (ImmediateOutcomes model: per event; EventScheduler: once per bout.)
	* 
	* Default: Clinical events have no effect on immune status except
	* secondarily via effects of treatment. */
// 	PENALISATION_EPISODES,
	
	/** @brief Baseline availability of humans is sampled from a gamma distribution
	* Infections introduced by mass action with negative binomial
	* variation in numbers of infection.
	* 
	* Default: New infections are introduced via a Poisson process as described
	* in AJTMH 75 (suppl 2) pp11-18. */
	NEGATIVE_BINOMIAL_MASS_ACTION,
	
	/* @brief An IPT model, no longer used
	* 
	* Does nothing if IPT is not present. */
// 	ATTENUATION_ASEXUAL_DENSITY,
	
	/** @brief Baseline availability of humans is sampled from a log normal distribution
	* 
	* Infections introduced by mass action with log normal variation in
	* infection rate.
	* 
	* Default: New infections are introduced via a Poisson process as described
	* in AJTMH 75 (suppl 2) pp11-18. */
	LOGNORMAL_MASS_ACTION,
	
	/** Infections are introduced without using preerythrocytic immunity. */
	NO_PRE_ERYTHROCYTIC,
	
	/** @brief Bug fixes in Descriptive & DescriptiveIPT within-host models.
	*
      * For new parameterisations, both MAX_DENS_CORRECTION and INNATE_MAX_DENS
      * should be used. When using parameter sets from an old fitting run which
      * didn't originally use these options, turn them off for consistency.
	* 
	* MAX_DENS_RESET is not used since it is unneeded when MAX_DENS_CORRECTION
	* is present and wouldn't make sense when not. */
	// @{
	MAX_DENS_CORRECTION,
	INNATE_MAX_DENS,
// 	MAX_DENS_RESET,
	//@}
	
	/** @brief Parasite densities are predicted from an autoregressive process
	*
	* Default: Parasite densities are determined from the descriptive model
	* given in AJTMH 75 (suppl 2) pp19-31 .*/
	DUMMY_WITHIN_HOST_MODEL,
	
	/** Clinical episodes occur if parasitaemia exceeds the pyrogenic threshold.
	* 
	* Default: Clinical episodes are a stochastic function as described in AJTMH
	* 75 (suppl 2) pp56-62. */
	PREDETERMINED_EPISODES,
	
	/** @brief The presentation model includes simulation of non-malaria fevers
	* 
	* Default: Non-malaria fevers are not simulated. */
	NON_MALARIA_FEVERS,
	
        //Deprecated: PK/PD code is enabled in all compatible within-host models
	/** @brief Use a PK & PD model for drug effects
	 *
	 * This enables simulation of the pharmacokinetics and pharmacodynamics
         * of drugs, allowing simulation of partial treatment. The alternate
         * treatment model gives drugs all-or-nothing effects, and is available
         * regardless of whether this option is enabled.
	 * 
         * The available PK/PD model, "LSTM", is that developed by colleagues
         * at the Liverpool School of Tropical Medicine.
         * 
         * Use of a 1-day infection model is required. */
// 	INCLUDES_PK_PD,
	
	/** @brief Use revised clinical and case management model, ClinicalEventScheduler
	* 
	* Default: use the Tediosi et al case management model (Case management as
	* described in AJTMH 75 (suppl 2) pp90-103), ClinicalImmediateOutcomes. */
	CLINICAL_EVENT_SCHEDULER,
	
	/** @brief Clinical episodes occur in response to a simple parasite density trigger
	* 
	* Default: Use the Ross et al presentation model (Clinical episodes are a
	* stochastic function as described in AJTMH 75 (suppl 2) pp56-62). */
	MUELLER_PRESENTATION_MODEL,
	
	/** @brief Simple heterogeneity
	* 
	* Defaults: No heterogeneity.
	* 
	* (Transmission) heterogeneity is incompatible with
	* NEGATIVE_BINOMIAL_MASS_ACTION and LOGNORMAL_MASS_ACTION because both try
	* to adjust _EIRFactor and it is not confirmed that the ways they do this is
	* compatible. */
	// @{
	/// @brief Allow simple heterogeneity in transmission
	TRANS_HET,
	/// @brief Allow simple heterogeneity in comorbidity
	COMORB_HET,
	/// @brief Allow simple heterogeneity in treatment seeking
	TREAT_HET,
	/// @brief Allow correlated heterogeneities in transmission and comorbidity
	COMORB_TRANS_HET,
	/// @brief Allow correlated heterogeneities in transmission and treatment seeking
	TRANS_TREAT_HET,
	/// @brief Allow correlated heterogeneities comorbidity and treatment seeking
	COMORB_TREAT_HET,
	/// @brief Allow correlated heterogeneities in transmission, comorbidity and treatment seeking
	TRIPLE_HET,
        // @}
        
	/** @brief Selection of within host models
	*/
        //@{
        /// Parasite densities are predicted from an empirical model
	EMPIRICAL_WITHIN_HOST_MODEL,
	
        /// Use Molineaux within host model
	MOLINEAUX_WITHIN_HOST_MODEL,
        
        /** Use Penny infection model. */
        PENNY_WITHIN_HOST_MODEL,
        // @}
	
	/** @brief Selection of gamma distribution for Molineaux or Penny within host models
	 */
	//@{
	/** Use Gamma distribution for mean duration (Molineaux model) */
	MEAN_DURATION_GAMMA,
	/** Use Gamma distribution for first local maximum (Molineaux model) */
	FIRST_LOCAL_MAXIMUM_GAMMA,
	/** Use Gamma distribution for first local maximum (Molineaux model) */
	PARASITE_REPLICATION_GAMMA,
	
	/** Use Gamma distribution for immune threshold (Penny model) */
	IMMUNE_THRESHOLD_GAMMA,
	
	/** Use Gamma distribution for update density (Penny model) */
	UPDATE_DENSITY_GAMMA,
	//@}
        
	/** Use the Garki density bias instead of the default one in the detection limit.
	 *
	 * The default bias corresponds to counting parasites and white blood cells
	 * (assuming a white blood cell density of 8000 per µl), the Garki bias to
	 * estimations from a probability function. */
	GARKI_DENSITY_BIAS,
	
	/** This has been removed; mass drug interventions can be used as a
         * replacement. */
// 	IPTI_SP_MODEL,
	
	/* Replaced by "onlyNewEpisode" attribute on SurveyOptions. */
// 	REPORT_ONLY_AT_RISK,
        
        /** Turn on vector life-cycle model. Allows better larviciding and
         * vector population dynamics modelling.
         * 
         * Requires vector model. */
        VECTOR_LIFE_CYCLE_MODEL,
        
        /** Turn on the simple mosquito population dynamics model (simpler
         * version of life-cycle model).
         * 
         * Requires vector model. */
        VECTOR_SIMPLE_MPD_MODEL,
        
        /** Sample case-specific densities P*c and P*m as a pair from one of
         * the 35 patient records. */
        MOLINEAUX_PAIRWISE_SAMPLE,
        
        /** Use a simple Vivax model instead of Falciparum.
         * 
         * See "Individual-Based Model for Plasmodium vvivax", Ross, Briet,
         * Hardy, Chitnis (unpublished?). */
        VIVAX_SIMPLE_MODEL,
        
        /** No longer used. */
//         PROPHYLACTIC_DRUG_ACTION_MODEL,
        
        /** Bug fixes:
         * 
         * Without this, the 5-day case management leaves uncomplicated cases
         * with indirect mortality untreated, and the 1-day case management 
         * forgets to apply indirect mortality if the sickness state doesn't
         * change.
         * 
         * This option fixes both bugs (though only one would have any effect,
         * depending on which case management model is used). */
        INDIRECT_MORTALITY_FIX,
        
        /** Potentially a bug-fix: for in-hospital severe malaria patients
         * where treatment fails to clear parasites, enabling this option
         * selects the use of hospital Case-Fatality-Rate (as described in the
         * AJTMH supplement); otherwise the community CFR is used (old model
         * behaviour, whether a bug or intended behaviour).
         * 
         * This is disabled by default since model parameters have been fitted
         * with this disabled. New models could be fit with the option enabled.
         */
        CFR_PF_USE_HOSPITAL,

     	/** By default 'nExpected' and 'nNewInfections' outputs are affected
     	 * by the PEV vaccine factor (the vaccine reduces the 
     	 * 'expectedNumInfections'). Enabling this option causes the vaccine 
     	 * to be applied AFTER infections have been created. Some infections 
     	 * will be immediately discarded with some probability based on the 
     	 * vaccine factor. With this option, 'nExpected' will be unaffected 
     	 * by the vaccine and will be higher while 'nNewInfections' will be 
     	 * similar on average.
     	 * 
     	 * This option is required when genotypes are used in combination 
     	 * with the vaccine.
     	 */
        VACCINE_GENOTYPE,

        
	// Used by tests; should be 1 more than largest option
	NUM_OPTIONS,
        
        IGNORE  // special value for use in string to enum lookup
    };
    
    
    /// Encapsulation for "modelVersion" xml attribute
    class ModelOptions {
    public:
	/** Return true if given option (from OptionCodes) is active.
         * 
         * Performance note: calling this a few times (e.g. during init) is
         * fine, but code needing a value repeatedly should cache it locally.
         */
	static inline bool option(OptionCodes code) {
	    return options.test( code );
	}
	
	/** Read options from the XML element. */
	static void init (const scnXml::OptionSet& options);
        
    private:
        // Reset opts to default. Used by unit tests.
        static inline void reset() {
            options.reset();
            options.set( MAX_DENS_CORRECTION );
            options.set( INNATE_MAX_DENS );
        }
        static inline void set(OptionCodes code) {
            options.set( code );
        }
        
	// The model options
	static std::bitset<NUM_OPTIONS> options;
	
	friend class ::UnittestUtil;	// Note: class is in base namespace
    };
} }
#endif
